2025-09-28 - Analysis Report
Okay, here's an analysis of Schrodinger Inc. (SDGR) based on the information you provided, presented in English with key numbers and an overall assessment.

**Report on Schrodinger Inc. (SDGR)**

**Company Overview:** Schrodinger Inc. is a company that develops software for drug discovery and materials science.

**1. Performance vs. S&P 500 (VOO)**

*   **SDGR Cumulative Return:** -54.39%
*   **VOO Cumulative Return:** 53.27%
*   **Absolute Divergence:** -72.2 (SDGR significantly underperforming VOO)
*   **Relative Divergence:** 3.6 (Indicates SDGR's underperformance is near its worst relative to its historical range against VOO).

**Alpha/Beta Analysis (Yearly CAGR, MDD, Alpha, Beta, Market Cap in Billions)**

| Year       | CAGR    | MDD    | Alpha   | Beta   | Cap(B) |
|------------|---------|--------|---------|--------|--------|
| 2020-2022  | -66.0%  | 78.2%  | -82.0%  | 0.1    | 1.4    |
| 2021-2023  | -64.0%  | 81.1%  | -82.0%  | -0.1   | 2.6    |
| 2022-2024  | -2.0%   | 81.1%  | -15.0%  | -0.1   | 1.4    |
| 2023-2025  | -8.0%   | 82.7%  | -43.0%  | -0.3   | 1.4    |

**Analysis:**

*   **Significant Underperformance:** SDGR has significantly underperformed the market (VOO) over all periods.
*   **High Volatility:** High Maximum Drawdown (MDD) values indicate substantial risk and price volatility.
*   **Negative Alpha:** Consistently negative alpha suggests SDGR's performance is worse than what would be expected based on market movements alone.
*   **Beta Around 1:** Beta values generally around 1 suggest the stock's volatility is similar to the overall market, but the 2021-2023 data shows 2.6 which is very volatile.

**2. Recent Price Action**

*   **Current Price:** \$19.30
*   **Previous Close:** \$19.03
*   **Change:** +1.42%
*   **5-day Moving Average:** 19.236
*   **20-day Moving Average:** 19.1145
*   **60-day Moving Average:** 20.0719

**Analysis:**

*   **Slight Uptick:** The current price is slightly above the 5-day and 20-day moving averages, suggesting a potential short-term uptrend.
*   **Below 60-day MA:** The price is still below the 60-day moving average, indicating that the longer-term trend may still be downward or sideways.
*   **Recent Price Change:** The +1.42% change suggests a positive intraday movement.

**3. Market Risk Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (Medium to High Investment Recommendation).
*   **RSI:** 48.62 (Neutral - neither overbought nor oversold).
*   **PPO:** 0.3595 (Close to zero, indicating that the price has been relatively stable recently and has not been trending strongly either up or down. A PPO value of 0.3595 is slightly above zero, which might suggest a weak upward trend. However, it's important to consider other indicators and the overall context to determine if this slight positive value is significant.)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (52 shares - Very Safe - MRI:0.90) Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Recent (20-day) Relative Divergence Change:** -1.3 (Short-term decline)
*   **Expected Return:** -1036.1% (Significantly Negative - indicating very poor expected returns compared to S&P 500 with long term investment (2+ years))

**Analysis:**

*   **Moderate Risk:** The MRI suggests a medium to high investment recommendation, but the significantly negative expected return tempers this.
*   **Neutral RSI:** RSI indicates no strong momentum in either direction.
*   **Hybrid Signal:** The signal recommends a fully invested position with a small monthly investment, but this recommendation should be viewed cautiously given the other negative indicators.
*   **Recent Divergence Change:** The recent negative change in relative divergence suggests short-term underperformance pressure.

**4. Recent News & Significant Events**

*   **Inducement Grants:** Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
*   **Valuation Evaluation:** Schrödinger (SDGR): Evaluating Valuation as Market Sentiment Remains Quiet
*   **Potential Rally:** Does Schrodinger (SDGR) Have the Potential to Rally 40.43% as Wall Street Analysts Expect?
*   **Conference Presentation:** Schrödinger to Present at Morgan Stanley Global Healthcare Conference
*   **Program Discontinuation:** Schrödinger Announces Discontinuation of SGR-2921 Program

**Analysis:**

*   **Mixed News:** The news is a mixed bag. Positive articles highlight potential rallies and valuation assessments. However, the discontinuation of the SGR-2921 program is a negative development.

**4-2) Analyst Opinions**

*   **Analyst Consensus:** None
*   **Mean (1=StrongBuy~5=Sell):** \-
*   **Opinions:** 9
*   **Target Price (avg/high/low):** 28.11 / 33.00 / 19.00
*Recent Rating Changes:
  • [0] :  →  ()
  • [1] :  →  ()
  • [2] :  →  ()
  • [3] :  →  ()

**Analysis:**

*   **No Analyst Consensus:** There is no clear consensus from analysts.
*   **Target Price:** The average target price of \$28.11 suggests potential upside, but this is significantly higher than the current price and should be viewed skeptically given the company's performance.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-08-06 | -0.59 | 0.05 B\$  |
| 2025-05-07 | -0.82 | 0.06 B\$  |
| 2024-11-12 | -0.52 | 0.04 B\$  |
| 2024-07-31 | -0.74 | 0.05 B\$  |
| 2025-08-06 | -0.74 | 0.05 B\$  |

**Analysis:**

*   **Consistent Losses:** The company is consistently reporting losses (negative EPS).
*   **Stable Revenue:** Revenue has been relatively stable.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | \$0.05B  | 47.77%        |
| 2025-03-31 | \$0.06B  | 52.26%        |
| 2024-12-31 | \$0.09B  | 72.61%        |
| 2024-09-30 | \$0.04B  | 50.24%        |
| 2024-06-30 | \$0.05B  | 66.20%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-06-30 | \$0.34B  | -12.59%   |
| 2025-03-31 | \$0.37B  | -16.01%   |
| 2024-12-31 | \$0.42B  | -9.54%    |
| 2024-09-30 | \$0.45B  | -8.49%    |
| 2024-06-30 | \$0.47B  | -11.40%   |

**Analysis:**

*   **Decreasing Equity:** Equity is trending downward, indicating potential financial strain.
*   **Negative ROE:** Consistently negative Return on Equity (ROE) confirms the company's inability to generate profits from its equity.
*   **Reasonable Profit Margins:** High profit margins may give positive insights into the company in the future.

**7. Overall Assessment**

Schrodinger Inc. (SDGR) presents a challenging investment case based on the data provided.

*   **Poor Historical Performance:** The stock has significantly underperformed the market and its historical performance.
*   **Financial Weakness:** Consistent losses, negative ROE, and decreasing equity are concerning.
*   **Mixed Signals:** While analyst target prices suggest potential upside, the lack of consensus and the company's financial performance make these targets questionable.
*   **Risk Factors:** High volatility and a negative expected return highlight the risks involved.
*   **Recent News:** Mixed news flow with positive valuation reports, the company presents at an investment conference, and one announcement of a program discontinuation.

**Conclusion:**

Based on the information available, an investment in SDGR appears risky. While there might be potential for a turnaround, the current financial performance and market sentiment suggest caution. Further research and due diligence are strongly recommended before making any investment decisions.
